Emboldened by their GSK probe, Chinese officials step up pharma snooping
19.05.2014 / Fierce Pharma
Pharma industry probes are far from over, China-based professionals say. And with the country trying desperately to drive down healthcare costs for its population of close to 1.4 billion, Big Pharma had best be careful. Local officials are making it clear that Big Brother is watching.